ROLE OF VITAMIN C AS AN ADJUVANT THERAPY IN PATIENTS WITH SEVERE PNEUMONIA IN TERMS OF REDUCED HOSPITAL STAY

T ZAHID; N HAIDER; R SAADAT; FT ZAHRA; H REHMAN; A FAROOQ

doi:10.54112/bcsrj.v2024i1.1335

Authors

T ZAHID Department of Paediatric Medicine, Children Hospital, Pakistan Institute of Medical Sciences, Islamabad, Pakistan
N HAIDER Department of Paediatric Medicine, Children Hospital, Pakistan Institute of Medical Sciences, Islamabad, Pakistan
R SAADAT Department of Paediatric Medicine, Children Hospital, Pakistan Institute of Medical Sciences, Islamabad, Pakistan
FT ZAHRA Department of Paediatric Medicine, Children Hospital, Pakistan Institute of Medical Sciences, Islamabad, Pakistan
H REHMAN Department of Paediatric Medicine, Children Hospital, Pakistan Institute of Medical Sciences, Islamabad, Pakistan
A FAROOQ Department of Paediatric Medicine, Children Hospital, Pakistan Institute of Medical Sciences, Islamabad, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1335

Keywords:

Vitamin C, Severe pneumonia, Pediatric pneumonia, Pneumonia treatment

Abstract

Vitamin C is well-known for its antioxidant and immune-boosting properties, which can theoretically influence respiratory infections. Numerous studies have explored the role of vitamin C in preventing and treating respiratory infections such as pneumonia in adults. However, there is limited on its effects as adjuvant treatment in pneumonia, in the pediatric population. We conducted this study to compare the effects of vitamin C vs placebo along with standard therapy, reducing the mean hospital stay duration in children with severe pneumonia. Methods: We conducted a randomized control trial over 1 year (1st September 2023 to 30th August 2024) in Children's Hospital, PIMs. We recruited 120 children aged 2 months to 60 months admitted with severe pneumonia. The patients were divided into two groups GROUP A and GROUP B by randomization using the lottery method. Group A received standard antibiotics plus 200 mg of vitamin C daily and Group B received standard antibiotics with a placebo. Duration of hospital stay, duration of fever, cough duration, days on oxygen, days to improve respiratory distress, and days to improve tachypnea were taken as outcomes Results: This study aimed to assess the clinical efficacy of Vitamin C supplementation in patients' children with severe pneumonia, focusing on its impact on hospital stay duration. Additional outcomes evaluated included the duration of fever, cough, oxygen use, respiratory distress, and tachypnea. The findings from our randomized controlled trial (RCT) revealed no statistically significant differences between the Vitamin C and placebo groups for any of these outcomes. This included hospital stay duration (p = 0.57), fever duration (p = 0.49), cough duration (p = 0.51), days on oxygen (p=0.73), days with respiratory distress (p=0.32), and duration of tachypnea (p-values= 0.93). Conclusion: Although the role of Vitamin C in immune support, its antioxidant activity and anti-inflammatory activity theoretically justify its use in pneumonia, the findings of our study conducted on children did not indicate any significant impact of Vitamin C use on the clinical progression of the disease.

Downloads

Download data is not yet available.

References

Sohail H, Neupane S. Prevalence of and factors associated with under-5 mortality in South Asia. International health. 2019;11(2):119-27.

Hameed W, Asim M, Saleem S, Avan BI. Inequalities in utilisation of essential antenatal services for women with disabilities in Pakistan: analysis of a cross-sectional demographic and health survey of Pakistan 2017–2018. BMJ open. 2023;13(7):e074262.

Mizgerd JP. Inflammation and pneumonia: why are some more susceptible than others? Clinics in chest medicine. 2018;39(4):669-76.

Kudagammana ST, Premathilaka S, Vidanapathirana G, Kudagammana W. Childhood mortality due to pneumonia; evidence from a tertiary paediatric referral center in Sri Lanka. BMC Public Health. 2024;24(1):1-8.

Sidabutar E. Analisis Faktor Risiko Kejadian Pneumonia Pada Balita di Kota Makassar= Analysis of Risk Factors for Pneumonia in Children Less Than Five Years in Makassar: Universitas Hasanuddin; 2023.

Kirolos A, Blacow RM, Parajuli A, Welton NJ, Khanna A, Allen SJ, et al. The impact of childhood malnutrition on mortality from pneumonia: a systematic review and network meta-analysis. BMJ Global Health. 2021;6(11):e007411.

Maggini S, Wenzlaff S, Hornig D. Essential role of vitamin C and zinc in child immunity and health. Journal of International Medical Research. 2010;38(2):386-414.

Cerullo G, Negro M, Parimbelli M, Pecoraro M, Perna S, Liguori G, et al. The long history of vitamin C: from alleged prevention of the common cold to perspectives investigation to counter COVID-19. Frontiers in Immunology. 2020.

Padhani ZA, Moazzam Z, Ashraf A, Bilal H, Salam RA, Das JK, et al. Vitamin C supplementation for prevention and treatment of pneumonia. Cochrane Database of Systematic Reviews. 2020(4).

Bhoite GM, Pawar SM, Bankar MP, Momin AA. Level of antioxidant vitamins in children suffering from pneumonia. Current Pediatric Research. 2011;15(1):11-3.

Maggini S, Beveridge S, Suter M. A combination of high-dose vitamin C plus zinc for the common cold. Journal of International Medical Research. 2012;40(1):28-42.

Sasazuki S, Sasaki S, Tsubono Y, Okubo S, Hayashi M, Tsugane S. Effect of vitamin C on common cold: randomized controlled trial. European journal of clinical nutrition. 2006;60(1):9-17.

Sharma Y, Sumanadasa S, Shahi R, Woodman R, Mangoni AA, Bihari S, et al. Efficacy and safety of vitamin C supplementation in the treatment of community-acquired pneumonia: a systematic review and meta-analysis with trial sequential analysis. Scientific Reports. 2024;14(1):11846.

Russell FM, Reyburn R, Chan J, Tuivaga E, Lim R, Lai J, et al. Impact of the change in WHO’s severe pneumonia case definition on hospitalized pneumonia epidemiology: case studies from six countries. Bulletin of the World Health Organization. 2019;97(6):386.

Yaqub A, RIAZ N, GHANI Z, GUL S. ROLE OF VITAMIN C IN CHILDREN HAVING PNEUMONIA. ISRA Medical Journal. 2015;7(4).

Mahalanabis D, Basak M, Paul D, Gupta S, Shaikh S, Wahed M, et al. Antioxidant vitamins E and C as adjunct therapy of severe acute lower-respiratory infection in infants and young children: a randomized controlled trial. European journal of clinical nutrition. 2006;60(5):673-80.

Lee S-I, Lim C-M, Koh Y, Huh J-W, Lee JS, Hong S-B. The effectiveness of vitamin C for patients with severe viral pneumonia in respiratory failure. Journal of Thoracic Disease. 2021;13(2):632.

Hume-Nixon M, Graham H, Russell F, Mulholland K, Gwee A, group AR. Review of the role of additional treatments including oseltamivir, oral steroids, macrolides, and vitamin supplementation for children with severe pneumonia in low-and middle-income countries. Journal of Global Health. 2022;12.

Khan IM, Shabbier A, Naeemullah S, Siddiqui FR, Rabia M, Khan SN, et al. Efficacy of vitamin C in reducing duration of severe pneumonia in children. J Rawalpindi Med Coll. 2014;18(1):55-7.

Moore A, Khanna D. The role of vitamin C in human immunity and its treatment potential against COVID-19: a review article. Cureus. 2023;15(1).